Clinical Trial Update: Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine

View source ↗

Summary

A pharmacoepidemiological study conducted at Central Hospital in Nancy, France, examining secondary hyperparathyroidism in patients with end-stage renal disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: ESRD | Status: COMPLETED